Release Date: 30/09/22 13:43 Summary: Full Year Statutory Accounts Price Sensitive: No Download Document 1.04MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%